GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Covalon Technologies Ltd (OTCPK:CVALF) » Definitions » Total Inventories

Covalon Technologies (Covalon Technologies) Total Inventories : $4.51 Mil (As of Dec. 2023)


View and export this data going back to 2007. Start your Free Trial

What is Covalon Technologies Total Inventories?

Covalon Technologies's total inventories for the quarter that ended in Dec. 2023 was $4.51 Mil. Covalon Technologies's average total inventories from the quarter that ended in Sep. 2023 to the quarter that ended in Dec. 2023 was $4.45 Mil.

In Ben Graham's calculation of Net-Net Working Capital, inventory is only considered worth half of its book value. Covalon Technologies's Net-Net Working Capital per share for the quarter that ended in Dec. 2023 was $0.28.

Days Inventory indicates the number of days of goods in sales that a company has in the inventory. Covalon Technologies's Days Inventory for the three months ended in Dec. 2023 was 300.44.

Inventory Turnover measures how fast the company turns over its inventory within a year. Covalon Technologies's Inventory Turnover for the quarter that ended in Dec. 2023 was 0.30.

Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue. Covalon Technologies's Inventory-to-Revenue for the quarter that ended in Dec. 2023 was 1.28.


Covalon Technologies Total Inventories Historical Data

The historical data trend for Covalon Technologies's Total Inventories can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Covalon Technologies Total Inventories Chart

Covalon Technologies Annual Data
Trend Sep14 Sep15 Sep16 Sep17 Sep18 Sep19 Sep20 Sep21 Sep22 Sep23
Total Inventories
Get a 7-Day Free Trial Premium Member Only Premium Member Only 6.48 5.44 3.71 3.72 4.39

Covalon Technologies Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
Total Inventories Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 4.82 5.06 5.71 4.39 4.51

Covalon Technologies Total Inventories Calculation

Total Inventories includes the raw materials, work-in-process goods and completely finished goods of a company. It is a portion of a company's current assets.


Covalon Technologies  (OTCPK:CVALF) Total Inventories Explanation

Inventory control is an important part of business operation. If a company does not have enough inventory, it may not be able to meet customers' required delivery time. If it has too much inventory, the cost of holding the inventory can be high.

1. In Ben Graham's calculation of Net-Net Working Capital (NNWC), inventory is only considered worth half of its book value.

Covalon Technologies's Net-Net Working Capital Per Share for the quarter that ended in Dec. 2023 is

Net-Net Working Capital Per Share (Q: Dec. 2023 )
=(Cash And Cash Equivalents+0.75 * Accounts Receivable+0.5 * Total Inventories-Total Liabilities
-Preferred Stock-Minority Interest)/Shares Outstanding (EOP)
=(6.181+0.75 * 2.587+0.5 * 4.509-3.441
-0-0)/24.6696
=0.28

2. Days Inventory indicates the number of days of goods in sales that a company has in the inventory.

Covalon Technologies's Days Inventory for the three months ended in Dec. 2023 is calculated as:

Days Inventory=Average Total Inventories (Q: Dec. 2023 )/Cost of Goods Sold (Q: Dec. 2023 )*Days in Period
=4.4515/1.352*365 / 4
=300.44

3. Inventory Turnover measures how fast the company turns over its inventory within a year.

Covalon Technologies's Inventory Turnover for the quarter that ended in Dec. 2023 is calculated as

Inventory Turnover=Cost of Goods Sold (Q: Dec. 2023 ) / Average Total Inventories (Q: Dec. 2023 )
=1.352 / 4.4515
=0.30

4. Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.

Covalon Technologies's Inventory to Revenue for the quarter that ended in Dec. 2023 is calculated as

Inventory-to-Revenue=Average Total Inventories (Q: Dec. 2023 ) / Revenue (Q: Dec. 2023 )
=4.4515 / 3.476
=1.28

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Be Aware

Manufacturers with durable competitive advantages have the advantage that the products they sell do not change, and therefore will never become obsolete. Buffett likes this advantage.

When identifying manufacturers with durable competitive advantage, look for inventory and net earnings that rise correspondingly. This indicates that the company is finding profitable ways to increase sales which called for an increase in inventory.

Manufacturers with inventories that spike up and down are indicative of competitive industries subject to boom and bust.


Covalon Technologies Total Inventories Related Terms

Thank you for viewing the detailed overview of Covalon Technologies's Total Inventories provided by GuruFocus.com. Please click on the following links to see related term pages.


Covalon Technologies (Covalon Technologies) Business Description

Traded in Other Exchanges
Address
1660 Tech Avenue, Unit 5, Mississauga, ON, CAN, L4W 5S7
Covalon Technologies Ltd is principally engaged in the business of developing, licensing, and selling medical technologies. The company develops advanced wound care line which is designed for the treatment of a wide range of wounds; and infection prevention products such as MediClear PreOp which is a breathable, transparent, self-adhesive silicone barrier film that conforms to the contours of the body. It also develops perioperative care products. The company generates its revenue through development contracts, licensing agreements, and distribution contracts, and sales.